NCT05388409Completed
Risk Factors for Portosinusoidal Vascular Disease in Kidney Transplant Recipients:
Risk Factors for Portosinusoidal Vascular Disease in Kidney Transplant Recipients: Case-control Study
Source: ClinicalTrials.gov · Last updated 26 Mar 2025
Brief summary (registry, in English)
To look for the factors of exposure present prior to the onset of Porto-Sinusoidal Vascular Disease (PSVD) and which can lead to the occurrence of PSVD after renal transplantation, and therefore to consider the identification of risk factors, in order to prevent or detect early signs of portal hypertention in predisposed patients and improve their prognosis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 12 (actual)
- First submitted
- 29 Apr 2022
- Start date
- 25 Oct 2021
- Primary completion date
- 7 Feb 2023
- Lead sponsor
- University Hospital, Caen
- NCT number
- NCT05388409
What you commit to
- Study type: Observational
- Participants enrolled: 12
- From 25 Oct 2021 to the primary completion date, 7 Feb 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- thrombocytopenia and/or abnormal liver tests and/or hepatic dysmorphism and/or portal hypertension signs
Other
- liver cirrhosis
- transplanted from an other organ
Who the study is looking for
- PSVD (between january 2000 and december 2021) after kidney transplantation or
- Kidney transplantation without PSVD or
- PSVD without kidney transplantation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de CAEN Coordinator of this site? Confirm its status | Caen | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.